360 High-Risk Vulnerability Immunization Tool V2.0 vs Remedio Smart Device Hardening: Side-by-Side Comparison (2026)

360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..

Remedio Smart Device Hardening: Automated device hardening and configuration management platform. built by Remedio. Core capabilities include Real-time dependency and context mapping for safe configuration changes, Continuous monitoring of Active Directory, MDM settings, GPOs, and devices, Automated detection and remediation of security misconfigurations..

Both serve the Endpoint Protection Platform market but differ in approach, feature depth, and target audience.

360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. Remedio Smart Device Hardening differentiates with Real-time dependency and context mapping for safe configuration changes, Continuous monitoring of Active Directory, MDM settings, GPOs, and devices, Automated detection and remediation of security misconfigurations.

360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). Remedio Smart Device Hardening is developed by Remedio. The vendor behind a product decides its roadmap, support, and longevity, so check each company's profile before you commit.

360 High-Risk Vulnerability Immunization Tool V2.0 and Remedio Smart Device Hardening serve similar Endpoint Protection Platform use cases. Review the feature comparison above to determine which fits your requirements.